NDC 50090-5508-01 - Lorazepam
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 50090-5508
- Requested NDC
- 50090-5508-01
- Package NDCs from labels
- 50090-5508-2, 50090-5508-0, 50090-5508-1, 50090-5508-01
- Manufacturer
- A-S Medication Solutions
- Effective date
- 2026-01-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Lorazepam - A-S Medication Solutions | A-S Medication Solutions | 2026-01-24 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Related label |
|---|---|---|
| 50090-5508-0 | 2023-02-06 | Lorazepam Tablets, USP CIV Rx only |
| 50090-5508-1 | 2023-02-06 | Lorazepam Tablets, USP CIV Rx only |
| 50090-5508-2 | 2023-02-06 | Lorazepam Tablets, USP CIV Rx only |
| 50090-5508-0 | 2023-01-30 | Lorazepam Tablets, USP CIV Rx only |
| 50090-5508-1 | 2023-01-30 | Lorazepam Tablets, USP CIV Rx only |
| 50090-5508-2 | 2023-01-30 | Lorazepam Tablets, USP CIV Rx only |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 50090-5508-0 | Lorazepam | 30 in 1 BOTTLE | TABLET | 30 | 9 | |
| 50090-5508-1 | Lorazepam | 100 in 1 BOTTLE | TABLET | 100 | 9 | |
| 50090-5508-2 | Lorazepam | 60 in 1 BOTTLE | TABLET | 60 | 9 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 50090-5508 | LORAZEPAM TABLET [A-S MEDICATION SOLUTIONS] | 7 | Current NDC, Legacy NDC, 3 package rows | 20241115_8361519b-be1a-4542-a782-d7cdfa153e86.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 50090-5508-0 | EA - Each | 50090-5508 | b2d8d933-6098-4d4f-8966-dc91477f2223 | 1 | 2024-12-10 |
| 50090-5508-1 | EA - Each | 50090-5508 | 7dbc1326-21c0-4da0-9db8-4829848c61c6 | 1 | 2024-12-10 |
| 50090-5508-2 | EA - Each | 50090-5508 | 3b7d0a63-e8bc-476b-8765-f77e8e269a98 | 1 | 2024-12-10 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Lorazepam | LORAZEPAM | Hikma Pharmaceuticals USA Inc. | b79b38ee-c29d-4099-964f-000031f47f5a | 2022-04-26 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | Aphena Pharma Solutions - Tennessee, LLC | 1c956cc1-9217-46e0-80a3-7c811163d3f1 | 2021-09-30 | Boxed warning, Warnings, Adverse reactions | 197902 O26FZP769L |
| Lorazepam | LORAZEPAM | Hikma Pharmaceuticals USA Inc. | 5ff82103-cc57-4af9-9362-82a7c686271d | 2021-03-31 | Boxed warning, Warnings, Adverse reactions | O26FZP769L |
| Lorazepam | LORAZEPAM | Aphena Pharma Solutions - Tennessee, LLC | a4fa14be-cef1-4b4b-b099-abde92f15145 | 2019-01-08 | Boxed warning, Warnings, Adverse reactions | 197900 O26FZP769L |
| Lorazepam | LORAZEPAM | Aphena Pharma Solutions - Tennessee, LLC | 08bd30b0-a1c1-4ec3-bb9c-b1d55ac59f75 | 2018-11-05 | Boxed warning, Warnings, Adverse reactions | ANDA078203 197902 O26FZP769L |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.